Namodenoson Recruiting Phase 2 Trials for Non-Alcoholic Steatohepatitis (NASH) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT04697810Namodenoson in the Treatment of Non-Alcoholic Steatohepatitis (NASH)